Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.15 4.17% 3.75 16,855,098 16:35:28
Bid Price Offer Price High Price Low Price Open Price
3.65 3.75 3.975 3.70 3.775
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -1.12 18
Last Trade Time Trade Type Trade Size Trade Price Currency
17:06:38 O 282,590 3.75 GBX

Hemogenyx Pharmaceuticals (HEMO) Latest News

More Hemogenyx Pharmaceuticals News
Hemogenyx Pharmaceuticals Investors    Hemogenyx Pharmaceuticals Takeover Rumours

Hemogenyx Pharmaceuticals (HEMO) Discussions and Chat

Hemogenyx Pharmaceuticals Forums and Chat

Date Time Title Posts
21/4/202110:32HEMO5,238
18/4/202100:43HEMO 2020/21 Discussion MODERATED3,215
14/4/202111:40Hemogenyx - 2021 Entry to clinical status273
22/2/202111:02Hemogenyx - Details on posters53
14/2/202116:33Thoughts on JHFH8

Add a New Thread

Hemogenyx Pharmaceuticals (HEMO) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:06:383.75282,59010,597.13O
15:35:283.7516,821630.79UT
15:25:253.7413,174492.56O
15:23:123.73215,6658,037.83O
15:20:543.74792.95O
View all Hemogenyx Pharmaceuticals trades in real-time

Hemogenyx Pharmaceuticals (HEMO) Top Chat Posts

DateSubject
21/4/2021
09:20
Hemogenyx Pharmaceuticals Daily Update: Hemogenyx Pharmaceuticals Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 3.60p.
Hemogenyx Pharmaceuticals Plc has a 4 week average price of 3.48p and a 12 week average price of 3.48p.
The 1 year high share price is 15.38p while the 1 year low share price is currently 1.55p.
There are currently 469,795,217 shares in issue and the average daily traded volume is 25,211,375 shares. The market capitalisation of Hemogenyx Pharmaceuticals Plc is £17,617,320.64.
21/4/2021
06:24
burtond1: Yet another collaboration with a giant pharmaceutical company for @HemogenyxPharma ?"When we get into clinical trials we achieve an inflexion point for #HEMO and the share price will follow"Chief Exec Dr @vmsandler expands further with @copytasterhttps://total-market-solutions.com/2021/04/hemogenyx-pharmaceuticals/
01/4/2021
13:22
tuan1: Every month MINT will convert 14 million shares and sell it on open market .that is the way they will get back 6.5 millions lent to Hemo . How do they convert is depen on how low share it is . The lower share price the more share they will get and sell . Option to choose 10% on share price when sign the deal have mass bring down share value untill they show get some way to have income . Only when it show future value people will jump in but not now . Good rns never down share but bad one do
30/3/2021
21:45
tommyknockers1: I have held for 18 months now and my opinion is no deal. The share price so close to a deal of this nature would be reacting differently if the deal was either a) in negotiation or b) secured. The share price spikes and subsequent falls would suggest RI hop and buy followed by reality setting in. So, deal or no deal? My vote is no deal...
30/3/2021
10:35
justhereforhemo: Not sure why your going on here Badger, any shares that have been placed as part of the past 2 conversions have went to investors in pre-arranged transfers they have not been dumped on the open market. I get that someone got tipped off when the last 14mil trade was registered and started dumping blocks of 100K shares but it was THAT dumping of 100k blocks that caused a teeny fall, 14mil shares never hit the open market so whoever has that advantage of getting tipped off really has not benefited by it. I get that this knowledge would be a massive advantage if the shares were being dumped on the open market, but they are not so its pretty useless. By my maths, based on recent share price and the fact its trending up IF Mint were to continue placing shares like they are with what appears to be facilitated buyers probably provided by Vlad then its likely there would only be an additional 120-170m sticky shares placed which would not increase shares in the free float and would not harm the SP, especially if any triggered a TR1 or an II declared they were the buyer. Given peers at this stage are all 100m + at this pre-clinical stage assuming a worst case scenario of 200m shares for the remainder of the 12mil thats still < 700m shares or 14p+ now. Given Eli are very likely to sign that completely blows that out of the water and given its probably going to happen fairly soon the CLNs will most likely just be paid off also to avoid having them continually used as a weapon by shorters and derampers for the next 2 years. What I have seen is that the share price has been taken down much harder and faster when there are big buy orders by MMs such as PEEL forcing the share price down so any selling to force the share price down ironically helps fill those orders so that it can recover faster. Anyway, this is my one post here until much later, be able to spend more time chatting next week when I am not working. You were able to dominate the share price for a while but news is too close, volume is up and your influence is gone. You can take some sick satisfaction in the fact that Hemo have had to part with more equity than they otherwise would have had too in terms of the 7.7m share for the fee and the conversions to date, if you hate hemo and vlad that much perhaps that knowledge will give you some comfort.
26/3/2021
16:16
justhereforhemo: Badger the MCap is 30m, the share price is rising and the shares are being placed with investors. If they convert more and place with investors at the fair market price as has been done twice now then fine, the MCap should be on level with its peers at 100-200mil pre clinical trials or deal with Eli so the market would easily tolerate the rest of the CLNs being digested that way. Personally I dont think there will be many more conversions, but if there are, and they happen like this? Then work away, its responsible and done in such a way as to minimise any damage to the share price I am fine with it.
07/3/2021
11:09
chimpychops81: You’re talking about them spending the whole £60m also. Which won’t happen. Drugs of this calibre get snapped up waaay before the expensive broader phase 2 and 3 trials. Firstly, Eli take CDX and then HEMO never spends another penny on it again. So right that off. HEMO CART we fund through phase one trials and still we will never need to draw down anywhere near the whole Loan and therefore be subject to conversion of it all as you inanely suggest. HEMO CAR T gets picked up at proof of concept AT THE LATEST. Just for a bit of fun work out what your holding will be worth when HEMO gets taken over at £1b down the line. Currently MCap say £30m rounded up for ease. That’s a multiple of x33. And say the HEMO total shares increase due to conversions heavily by MINT converting 900m shares and reducing your holdings in % terms by a third. (Won’t happen imo but let’s just say) Then you end up with a diluted holding of 1.9p at current levels but which is then worth 33x due to HEMOs successful drug production. 62.7p a share after an enormous dilution which is not happening any time soon. The higher price they convert shares the less impact any conversion will have.m as they’ll get less and less shares. 93% dilution will NEVER HAPPEN anyway as we won’t draw the whole capital for starters never mind it never being MINTs intention. So you see it’s a trade off between dilution reducing value of holding but a far far superior upside potential. Seems a lot brighter when there’s balance to the facts doesn’t it Badger. “Investments can fall as well as rise and you may not get back the amount you invested”
06/3/2021
15:28
justhereforhemo: Jotoha, the company took CLNs to raise funds, on speaking to a number of experts they were pretty blunt and told me as soon as a company draws down on a CLN some people will short, every time its going to happen, if the lender decides to screw them straight off the bat then it's pure profit. Problem for badger is that Mint didn't screw over hemo and ever since badger has been doubling down. Trying to force down the share price but will no actual exit plan. The smart move would have been to short literally the second a date was given for the draw down, wait for a week or so and either mint would start converting big chunks almost daily, or they would not. If not the smart move is to flip, close shorts, take a small loss and go long. Anyway, it is what it is. With CLNs you can get screwed, hemo could have had significant dilution without any help or lies from badger. Since that's not happening he now needs the share price to drop and a significant sell off of shares to allow him to exit his positions in a profit. I would say badger is a good few million shares short and as such as much as he could short millions of shares more and force down the sp, that does not help him if he can't close off all his positions before the share price rockets. This is a no win scenario for everyone but the market makers who always win. Badger will lose when he tries to close out, but the rest of us have also lost too, so many good RNS's that should have seen us up in the 20s and 30s ruined by his actions. Sp will bounce and fly but it will still be tainted for a long time.
22/2/2021
11:24
justhereforhemo: You can smell the sweat of fear all the way over here from as far away as Hong Kong. For sure Peter got a few others to sell, for sure he dropped the share price a little more. He will have put his account into more profit in doing so giving him more money to leverage to short more Hemogenyx shares. However.... He cant just close all positions at once, he is a victim of his own success, as he drove down the price for himself he drove it down for others. The free float is been nibbled, whatever shares he has shorted, they are gone. Yes the first few blocks he may be able to close of easy enough.... Maybe a few hundred thousand... But as he starts to close he will be seeing the share price tick up and up... his profits will start to disappear. He is trading against himself right now, the MMs will win and he will burn in the end.
19/2/2021
14:12
justhereforhemo: Please dont hold me accountable for you losing money, you bet against a company with a massive following and a strong pipeline. There are lots of people keen to invest in Hemo who are waiting for other shares or investments to pay off first before they jump into Hemo, but because the share price dropped so low they started early. I wish I was responsible for the rise, but as much as you may wish to blame me I cant take credit. Fact is lower the share price is the more people will weigh up the benefits of waiting for that other investment over getting hemo while its stupidly low. Im not really sure why you have even bothered keeping engaging with me here? It really does seem pointless, nobody else bothers to read and all it does is give me ammo to use against you and allowed me to prove to people that you are indeed responsible for the fall lately. And all that has done is given people confidence to invest and motivation as they like to burn shorts. Like had you just sold or shorted and never said a word, just kept your mouth shut, people MIGHT have wrongly assumed it was Mint back at the start and panicked and sold, but literally the post after post of panic spam by someone who says they are not invested is just a big massive neon sign saying "IM SHORTING! Anyway, I am not going to waste my time engaging with you over the weekend and Monday morning... Well I dont expect to see you back on this board for a while if you get wiped out so might aswell just be straight with you. I do admire what you have done even though I dont agree with you. I wish you had picked a company like Dukemount which deserves to be shorted as its going to end up going bust and the constant ramping and pumping is pathetic, now going on about a perfect green shell? Come on. I am going to assume you both stop posting shortly, if thats monday then goodbye its been an experience, I have zero intention of following you if you decide to try again on some other share. In future try not to let emotion control you so much, you left yourselves wide open.
18/2/2021
16:22
justhereforhemo: yea it does seem crazy to risk it on a share like hemo where you really could get burnt so easy. Like 500k shares, I assume he sold at 6p or below 6, like 5.9p. So for him to close that out the share price has to tank to atleast 5.8p on the ask right? That is a big ask. Where as going long which many people do when they see the share price falling, going long at 6p you are in profit at 6.2p. Its just so much easier to make a killing going long at this price, I dont really understand the logic unless its just hate and its worked for so long in the past.
Hemogenyx Pharmaceuticals share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
HEMO
Hemogenyx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210421 18:42:27